Fintel reports that on November 5, 2024, JP Morgan initiated coverage of Camp4 Therapeutics (NasdaqGM:CAMP) with a Overweight recommendation.
Analyst Price Forecast Suggests 173.74% Upside
As of June 12, 2024, the average one-year price target for Camp4 Therapeutics is $25.51/share. The forecasts range from a low of $6.97 to a high of $60.38. The average price target represents an increase of 173.74% from its latest reported closing price of $9.32 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Camp4 Therapeutics is 339MM, an increase of 96,697.14%. The projected annual non-GAAP EPS is 0.41.
What is the Fund Sentiment?
There are 2 funds or institutions reporting positions in Camp4 Therapeutics. This is an decrease of 3 owner(s) or 60.00% in the last quarter. Total shares owned by institutions decreased in the last three months by 66.67% to 0K shares.
What are Other Shareholders Doing?
Huntington National Bank holds 0K shares representing 0.00% ownership of the company. No change in the last quarter.
Calamp Background Information
(This description is provided by the company.)
CalAmp Corporation is a global technology solutions pioneer transforming the mobile connected economy. The company helps reinvent business and improve lives around the globe with technology solutions that streamline complex mobile IoT deployments and bring intelligence to the edge. Its software and subscription-based services, scalable cloud platform and intelligent devices collect and assess business-critical data from mobile assets and their contents. CalAmp calls this The New How, facilitating cient decision making, optimizing mobile asset utilization and improving road safety. Headquartered in Irvine, California, CalAmp has been publicly traded since 1983 and has 20 million products installed and over 1.3 million software and services subscribers worldwide. Synovia™, Tracker™ and Here Comes The Bus® are CalAmp brands.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
